116 related articles for article (PubMed ID: 9135492)
1. Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.
Jelić S; Kovcin V; Milanović N; Babović N; Kreacić M; Ristović Z; Vlajić M; Filipović-Ljesković I
Eur J Cancer; 1997 Feb; 33(2):220-5. PubMed ID: 9135492
[TBL] [Abstract][Full Text] [Related]
2. High-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.
Jelić S; Vuletić L; Milanović N; Tomasević Z; Kovcin V
Tumori; 1990 Oct; 76(5):467-71. PubMed ID: 2256192
[TBL] [Abstract][Full Text] [Related]
3. Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
Lopez M; Carpano S; Di Lauro L; Vici P; Conti EM
Oncology; 1991; 48(3):230-3. PubMed ID: 2023703
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin 150 mg/m2-cisplatin versus epirubicin 180 mg/m2-cisplatin for advanced soft tissue sarcoma.
Jelić S; Babović N; Kreacić M; Matković S; Milanović N; Gavrilović D; Tomasević Z
Int J Clin Pharmacol Res; 1999; 19(4):129-38. PubMed ID: 10939030
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
[TBL] [Abstract][Full Text] [Related]
6. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study.
Chevallier B; Leyvraz S; Olivier JP; Fargeot P; Facchini T; Vo Van ML
Cancer Invest; 1993; 11(2):135-9. PubMed ID: 8462014
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy with high dose of anthracyclines combined with cisplatin in the treatment of soft tissue sarcomas].
Jelić S; Milanović N; Kovcin V; Tomasević Z; Vuletić L
Srp Arh Celok Lek; 1994; 122(9-10):265-8. PubMed ID: 17977432
[TBL] [Abstract][Full Text] [Related]
8. Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study.
Nielsen D; Dombernowsky P; Larsen SK; Hansen OP; Skovsgaard T
Cancer Chemother Pharmacol; 2000; 46(6):459-66. PubMed ID: 11138459
[TBL] [Abstract][Full Text] [Related]
9. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
10. [Polychemotherapy of advanced soft tissue sarcomas with 4'-epi-doxorubicin (4'-Epi-DX) and cisplatin (DDP)].
Sauer H; Mair W; Fink U; Rückle H; Mjaaland I; Wilmanns W
Onkologie; 1986 Aug; 9 Suppl 1():24-8. PubMed ID: 3528967
[TBL] [Abstract][Full Text] [Related]
11. High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
Nielsen OS; Dombernowsky P; Mouridsen H; Crowther D; Verweij J; Buesa J; Steward W; Daugaard S; van Glabbeke M; Kirkpatrick A; Tursz T
Br J Cancer; 1998 Dec; 78(12):1634-9. PubMed ID: 9862576
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study].
Becouarn Y; Bui BN; Kerbrat P; Chauvergne J; Brunet R; Robert J
Bull Cancer; 1987; 74(2):109-16. PubMed ID: 3475140
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of epirubicin in advanced soft tissue sarcoma.
Chevallier B; Montcuquet P; Fachini T; Nguyen Bui B; Kerbrat P; Bastit P; Vo Van ML
Bull Cancer; 1990; 77(10):991-5. PubMed ID: 2249019
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
15. Epirubicin and ifosfamide in advanced soft tissue sarcomas.
Frustaci S; Foladore S; Buonadonna A; De Paoli A; Crivellari D; Carbone A; Sorio R; Morassut S; Monfardini S
Ann Oncol; 1993 Sep; 4(8):669-72. PubMed ID: 8240997
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide and epirubicin combination in untreated sarcomas: two treatment schedules.
Serrone L; Zeuli M; Papaldo P; Nardoni C; Pacetti U; Cognetti F
Onkologie; 2001 Oct; 24(5):465-8. PubMed ID: 11694773
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of cisplatin and etoposide in children with advanced soft tissue sarcoma: a report from the Italian Cooperative Rhabdomyosarcoma Group.
Carli M; Perilongo G; di Montezemolo LC; De Bernardi B; Ceci A; Paolucci G; Pianca C; Calculli G; Di Tullio MT; Grotto P
Cancer Treat Rep; 1987 May; 71(5):525-7. PubMed ID: 3567976
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of cisplatin plus epirubicin or doxorubicin for advanced epithelial ovarian carcinoma. A multicenter trial.
Homesley HD; Harry DS; O'Toole RV; Hoogstraten B; Franklin EW; Cavanagh D; Nahhas WA; Smith JJ; Lovelace JV
Am J Clin Oncol; 1992 Apr; 15(2):129-34. PubMed ID: 1553900
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of a rapid etoposide-cisplatin regimen in paediatric soft tissue sarcomas.
Phillips MB; Pinkerton CR
Eur J Cancer; 1992; 28(2-3):399-403. PubMed ID: 1591053
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.
Cao J; Huang XE; Liu J; Wu XY; Lu YY
Asian Pac J Cancer Prev; 2013; 14(12):7171-7. PubMed ID: 24460271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
